Rays of Belief Peer Comparison
NSE: MOMSBELIEF | BSE: 544906
₹257.00
As on 05-Nov-2026 10:24IST
Market cap
₹528 Cr
Revenue (TTM)
₹82 Cr
P/E Ratio
106.4
P/B Ratio
3.1
Div. Yield
0 %
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
528 | 219 | 144 | 34 | 27 |
Revenue (₹ Cr) |
82 | 57 | 26 | 17 | 0 |
Net Profit (₹ Cr) |
4.96 | 0.15 | -0.45 | 1.93 | -8.72 |
Net Margin (%) |
6.04 | 0.26 | -1.72 | 10.69 | -17,442.00 |
RoE (%) |
16.10 | 0.26 | -3.41 | 5.30 | -60.02 |
Price to Earnings |
106.41 | 1,460.60 | -- | 17.39 | -- |
Price-To-Book |
3.14 | 3.61 | 11.85 | 0.99 | 2.37 |
Income Statement (₹ Cr)
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Operating Revenue
|
81.66 | 53.71 | 24.98 | 16.39 | 0.02 |
|
Total Income
|
82.06 | 54.89 | 25.50 | 17.42 | 0.05 |
|
Total Expenditure
|
69.31 | 50.16 | 23.52 | 14.57 | 8.73 |
|
EBITDA
|
12.35 | 3.55 | 1.46 | 1.83 | -8.71 |
|
Depreciation
|
4.31 | 3.75 | 1.54 | 0.59 | 0.00 |
|
EBIT
|
8.04 | -0.20 | -0.08 | 1.23 | -8.72 |
|
Interest
|
1.54 | 1.03 | 0.39 | 0.12 | 0.00 |
|
Other Income
|
0.40 | 1.18 | 0.52 | 1.03 | 0.03 |
|
Exceptional Items
|
-- | 0.00 | -- | -- | -- |
|
Profit before Tax
|
6.90 | -0.05 | 0.05 | 2.15 | -8.69 |
|
Provision for Tax
|
1.94 | -0.13 | -- | 0.41 | -- |
|
Profit after Tax
|
4.96 | 0.08 | 0.05 | 1.73 | -8.69 |
Liabilities (₹ Cr)
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
30.81 | 60.14 | 12.23 | 33.56 | 11.75 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
0.95 | 12.92 | 3.16 | -1.18 | 0.09 |
|
Current Liabilities
|
13.62 | 9.34 | 3.11 | 1.90 | 2.54 |
|
Total Liabilities
|
50.87 | 82.60 | 18.51 | 35.47 | 14.38 |
Assets (₹ Cr)
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
12.62 | 71.03 | 13.92 | 31.34 | 11.84 |
|
Current Assets
|
32.77 | 11.37 | 4.59 | 2.94 | 2.54 |
|
Total Assets
|
50.87 | 82.60 | 18.51 | 35.47 | 14.38 |
|
Total Debt*
|
3.61 | 12.10 | 1.35 | 1.61 | 1.66 |
|
Net Current Assets
|
19.14 | 2.03 | 1.47 | 1.04 | 0.01 |
|
Contingent Liabilities
|
-- | 0.99 | 1.12 | 0.09 | -- |
Cashflow (₹ Cr)
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.94 | 3.02 | 1.45 | 0.96 | -4.26 |
|
Cash Flow from Investing Activities
|
-6.18 | -12.37 | -0.80 | -0.49 | 3.26 |
|
Cash from Financing Activities
|
6.04 | 9.03 | -1.14 | -1.42 | 2.63 |
|
Net Cash Inflow / Outflow
|
-2.09 | -0.32 | -0.49 | -0.95 | 1.63 |
Ratios
Profitability Ratios
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
ROCE (%)
|
24.53 | 1.47 | 3.26 | 6.00 | -62.45 |
|
ROE (%)
|
16.10 | 0.13 | 0.42 | 4.81 | -73.22 |
|
ROA (%)
|
10.93 | 0.11 | 0.28 | 4.57 | -58.00 |
|
EBIT Margin (%)
|
15.62 | 8.81 | 7.92 | 17.42 | -47,884.92 |
|
Net Margin (%)
|
6.04 | 0.15 | 0.20 | 9.95 | -17,511.30 |
|
Cash Profit Margin (%)
|
11.35 | 7.13 | 6.36 | 14.20 | 0.00 |
Growth Ratios
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.00 | 8.38 | 13.56 | -0.92 | -- |
|
EBIT Growth (%)
|
-- | -2.68 | -49.43 | -71.03 | -3,282.58 |
|
Net Profit Growth (%)
|
0.00 | -89.12 | -97.52 | -77.60 | -3,247.46 |
|
EPS Growth (%)
|
0.00 | -89.11 | -97.53 | -77.60 | -1,765.31 |
|
Book Value Growth (%)
|
0.00 | 0.23 | 0.12 | -12.87 | -1.83 |
Valuation Ratios
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 2,618.86 | 1,121.49 | 24.66 | 0.00 |
|
Price / Book Value
|
0.00 | 3.50 | 4.70 | 1.27 | 3.07 |
|
Dividend Yield (%)
|
-- | 0.00 | 0.00 | 2.74 | 0.00 |
|
EV/EBITDA
|
1.02 | 46.31 | 28.88 | 15.04 | -4.16 |
|
Market Cap (₹ Cr)
|
0.00 | 210.77 | 57.49 | 42.75 | 36.08 |
Solvency Ratios
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.12 | 0.20 | 0.11 | 0.05 | 0.14 |
|
Short term debt to equity ratio
|
0.03 | -- | -- | 0.05 | 0.14 |
|
Current Ratio
|
2.41 | 1.22 | 1.47 | 1.55 | 1.00 |
|
Quick Ratio
|
2.41 | 0.81 | 1.25 | 1.11 | 1.00 |
|
Interest Coverage
|
5.48 | 0.95 | 1.13 | 19.41 | -7,532.35 |
Operating Efficiency Ratios
| Rays of Belief | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
22.15 | 2.25 | 6.94 | 2.93 | 108.10 |
|
Asset Turnover
|
1.80 | 0.71 | 1.39 | 0.43 | 0.00 |
|
Receivable days
|
80.85 | 8.60 | 29.85 | 10.09 | 0.00 |
|
Inventory Days
|
0.00 | 26.04 | 8.83 | 17.46 | 0.00 |
|
Payable days
|
-- | 72.50 | 75.83 | 0.00 | 582.01 |
|
Cash Conversion Cycle
|
-- | -37.86 | -37.16 | 27.55 | -582.01 |